论文部分内容阅读
本项目开发的创新产品“丹参酮Ⅱ A磺酸钠注射液”为心血管类疾病治疗药物,临床上主要用于冠心病、心绞痛、心肌梗死,也可用于室性早搏,属于生物与新医药技术领域重大品种。丹参酮Ⅱ A磺酸钠的创制是我们以“中药西做”思路对中药材有效活性成分进行现代化改造的一次尝试。公司积极推进该项目的产业化实施,建设了丹参酮Ⅱ A磺酸钠原料与注射液GMP生产线,于2002年实现产品成功上市,商品名“诺新康”。于2004年
Innovative products developed in this project “Tanshinone Ⅱ A sodium sulfonate injection” for the treatment of cardiovascular diseases, clinically mainly used for coronary heart disease, angina, myocardial infarction, ventricular premature beats can also be used for biological and new Major medicinal technology varieties. The creation of sodium tanshinone Ⅱ A sulfonate is an attempt to modernize the effective active ingredients of Chinese herbal medicines with the idea of “traditional Chinese medicine and western medicine”. The company actively promote the industrialization of the project, the construction of a raw material of sodium tanshinone Ⅱ A sulfonate and injection GMP production line in 2002, the successful listing of the product, the trade name “Connaught new health ”. In 2004